Irbesartan Improves Endothelial Dysfunction, Abnormal Lipid Profile, Proteinuria and Liver Dysfunction in Zucker Diabetic Fatty Rats Independent of Glucose and Insulin Levels
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2011.307
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Spandidos Publications